Treatment outcomes with first-line (1L) nab-Paclitaxel + gemcitabine (AG) and FOLFIRINOX (FFX) in metastatic pancreatic adenocarcinoma (mPAC).
暂无分享,去创建一个
T. Cartwright | H. Babiker | J. Espirito | C. Pelletier | M. Patel | Thomas W. Wilson | Monika Parisi